Pharmaceuticals and healthcare
View this page in: Tiếng Việt
The pharmaceutical and healthcare industries are undergoing a period of profound transformation. Many analysts agree that the industry is moving from the era of the "blockbuster drug" to a new operating model known as personalized medicine. While achieving success in research and development continues to define those who will be the industry's winners and losers, other issues are increasingly demanding the attention of top management.
These issues include navigating the challenges of global regulatory compliance, optimizing the supply chain, achieving marketing excellence and effectively managing organizational complexity on a global scale. These issues, along with increased scrutiny of the industry's business practices and difficult questions over the safety of marketed drugs have created substantial tensions between the industry and its stakeholders.
How PwC Vietnam can help you:
We have made a deep commitment to understanding the forces that are impacting these sectors and developing and delivering solutions that help our clients' achieve their financial, operational and strategic objectives.
We know the challenges you face in today's marketplace
Explore the challenges that we hear about every day. See what services and solutions PwC has to offer.
Our latest thinking for pharmaceuticals and life sciences
- Emerging mHealth: Paths for growth
-
Emerging mHealth: Paths for growth
In this PwC-commissioned report from the Economist Intelligence Unit (EIU), patients, doctors and payers share their views on mHealth. Find out what they told us, and learn more about the potential of mobile health in developed and emerging markets, the challenges, and the impact on stakeholders.
- Medical cost trend: Behind the numbers 2013
-
Medical cost trend: Behind the numbers 2013
This report looks at the projected increase in the cost of medical services for 2013. Medical cost trend is the primary factor in setting health insurance premiums. Commercial insurers and large employers use this information to estimate what the same health plan would cost in the following year.
- Unleashing value: The changing payment landscape for the US pharmaceutical industry
-
Unleashing value: The changing payment landscape for the US pharmaceutical industry
Pharmaceuticals are competing over a shrinking piece of the prescription drug pie. Changes in the industry are hastening the arrival of an outcomes-based world where the value of a drug tracks much more closely with its impact on patient health.
- MoneyTree: Mixed momentum
-
MoneyTree: Mixed momentum
The Biotechnology and Medical Devices industries saw venture capitalists invest a total of $1.5 billion in the first quarter of 2012.
- Taking advantage of the Medtech market potential in India: Success will hinge on operating model innovation
-
Taking advantage of the Medtech market potential in India: Success will hinge on operating model innovation
To sustain revenue and market share growth in India, global medical technology companies should look to tailor their business strategies and operating models to the needs of India’s unique marketplace.
- Social media likes healthcare: From marketing to social business
-
Social media likes healthcare: From marketing to social business
With one half of health industry executives saying they are concerned about how to integrate social media data into their business strategy there is a recognition that social media presents a significant industry challenge.
- Needles in a haystack: Seeking knowledge with clinical informatics
-
Needles in a haystack: Seeking knowledge with clinical informatics
Incorporating clinical informatics across a healthcare organization will be essential as the reimbursement landscape evolves to a more outcomes-based approach.
